ConicMeds

ConicMeds expertise in the development of innovative drugs for the treatment of pathologies associated with cellular lipointoxication.

ConicMeds is active in the biotechnology, pharmaceutical space based in European Union (EU), Europe, Middle East, and Africa (EMEA), founded in 2017.

Its activity falls under biotechnology, pharmaceutical; the profile below is assembled from public directory data.

Its base of operations is European Union (EU), Europe, Middle East, and Africa (EMEA).

Directory data places it at the Private company stage.

Recorded headcount: c_00001_00010 employees.

Sector	Biotechnology, Pharmaceutical
Headquarters	European Union (EU), Europe, Middle East, and Africa (EMEA)
Founded	2017
Employees	c_00001_00010
Stage	Private company

Website: www.conicmeds.com

Emails and contact routes are reserved for registered members.
Create a free account

Browse related